Global Insulin Market Survey and Trend Research 2018
Summary
Insulin (from the Latin, insula meaning island) is a peptide hormone produced by beta cells of the pancreatic islets. It regulates the metabolism of carbohydrates, fats and protein by promoting the absorption of, especially, glucose from the blood into fat, liver and skeletal muscle cells.In these tissues the absorbed glucose is converted into either glycogen via glycogenesis or fats (triglycerides) via lipogenesis, or, in the case of the liver, into both.Glucose production (and excretion into the blood) by the liver is strongly inhibited by high concentrations of insulin in the blood.Circulating insulin also affects the synthesis of proteins in a wide variety of tissues. It is therefore an anabolic hormone, promoting the conversion of small molecules in the blood into large molecules inside the cells. Low insulin levels in the blood have the opposite effect by promoting widespread catabolism.
This report describes the development of the industry by upstream & downstream, industry overall and development, key companies, as well as type segment & market application and so on, and makes a scientific prediction for the development industry prospects on the basis of analysis, finally, analyzes opportunities for investment in the industry at the end of the report.
Industry Chain
Insulin (from the Latin, insula meaning island) is a peptide hormone produced by beta cells of the pancreatic islets. It regulates the metabolism of carbohydrates, fats and protein by promoting the absorption of, especially, glucose from the blood into fat, liver and skeletal muscle cells.In these tissues the absorbed glucose is converted into either glycogen via glycogenesis or fats (triglycerides) via lipogenesis, or, in the case of the liver, into both.Glucose production (and excretion into the blood) by the liver is strongly inhibited by high concentrations of insulin in the blood.Circulating insulin also affects the synthesis of proteins in a wide variety of tissues. It is therefore an anabolic hormone, promoting the conversion of small molecules in the blood into large molecules inside the cells. Low insulin levels in the blood have the opposite effect by promoting widespread catabolism.
This report describes the development of the industry by upstream & downstream, industry overall and development, key companies, as well as type segment & market application and so on, and makes a scientific prediction for the development industry prospects on the basis of analysis, finally, analyzes opportunities for investment in the industry at the end of the report.
Industry Chain
- Raw Materials
- Cost
- Technology
- Consumer Preference
- History
- Development & Trend
- Market Competition
- Trade Overview
- Policy
- Regional Market
- Production Development
- Sales
- Regional Trade
- Regional Forecast
- Company Profile
- Product & Service
- Business Operation Data
- Market Share
- Market Features
- Investment Opportunity
- Investment Calculation
PART 1 INDUSTRY OVERVIEW
1.1 Insulin Industry
1.1.1 Definition
1.1.2 Industry Trend
1.2 Industry Chain
1.2.1 Upstream
1.2.2 Technology
1.2.3 Cost Structure
1.2.4 Consumer Preference
1.2.2 Downstream
PART 2 INDUSTRY OVERALL
2.1 Industry History
2.2 Development Prospect
2.3 Competition Structure
2.4 Relevant Policy
2.5 Trade Overview
PART 3 INSULIN MARKET BY PRODUCT
3.1 Products List of Major Companies
3.2 Market Size
3.3 Market Forecast
4 KEY COMPANIES LIST
4.1 Novartis (Company Overview, Sales Data etc.)
4.1.1 Company Overview
4.1.2 Products and Services
4.1.3 Business Analysis
4.2 Novo Nordisk (Company Overview, Sales Data etc.)
4.2.1 Company Overview
4.2.2 Products and Services
4.2.3 Business Analysis
4.3 Boehringer Ingelheim (Company Overview, Sales Data etc.)
4.3.1 Company Overview
4.3.2 Products and Services
4.3.3 Business Analysis
4.4 Bristol-Myers Squibb (Company Overview, Sales Data etc.)
4.4.1 Company Overview
4.4.2 Products and Services
4.4.3 Business Analysis
4.5 MannKind (Company Overview, Sales Data etc.)
4.5.1 Company Overview
4.5.2 Products and Services
4.5.3 Business Analysis
4.6 MannKind (Company Overview, Sales Data etc.)
4.6.1 Company Overview
4.6.2 Products and Services
4.6.3 Business Analysis
4.7 Sanofi (Company Overview, Sales Data etc.)
4.7.1 Company Overview
4.7.2 Products and Services
4.7.3 Business Analysis
4.8 Merck (Company Overview, Sales Data etc.)
4.8.1 Company Overview
4.8.2 Products and Services
4.8.3 Business Analysis
4.9 Bioton (Company Overview, Sales Data etc.)
4.9.1 Company Overview
4.9.2 Products and Services
4.9.3 Business Analysis
4.10 GEA (Company Overview, Sales Data etc.)
4.10.1 Company Overview
4.10.2 Products and Services
4.10.3 Business Analysis
4.11 Emisphere (Company Overview, Sales Data etc.)
4.12 Salix Pharmaceuticals (Company Overview, Sales Data etc.)
4.13 Gan & Lee (Company Overview, Sales Data etc.)
4.14 Dongbao (Company Overview, Sales Data etc.)
4.15 United Laboratories (TUL) (Company Overview, Sales Data etc.)
4.16 Takeda Pharmaceutical Company (Company Overview, Sales Data etc.)
4.17 Shihuida PHARMA Group (Company Overview, Sales Data etc.)
4.18 Henan Tian Fang Pharmaceutical (Company Overview, Sales Data etc.)
4.19 Disha Pharmaceutical Group (Company Overview, Sales Data etc.)
PART 5 MARKET COMPETITION
5.1 Companies Competition
5.2 Industry Competition Structure Analysis
5.2.1 Rivalry
5.2.2 Threat of New Entrants
5.2.3 Substitutes
5.2.4 Bargaining Power of Suppliers
5.2.5 Bargaining Power of Buyers
PART 6 MARKET DEMAND BY SEGMENT
6.1 Demand Situation
6.1.1 Industry Application Status
6.1.2 Industry SWOT Analysis
6.1.2.1 Strengths
6.1.2.2 Weaknesses
6.1.2.3 Opportunities
6.1.2.4 Threats
6.2 Major Customer Survey
6.3 Demand Forecast
PART 7 REGION OPERATION
7.1 Regional Market
7.2 Production and Sales by Region
7.2.1 Production
7.2.2 Sales
7.2.3 Trade
7.3 Regional Forecast
PART 8 MARKET INVESTMENT
8.1 Market Features
8.1.1 Product Features
8.1.2 Price Features
8.1.3 Channel Features
8.1.4 Purchasing Features
8.2 Investment Opportunity
8.2.1 Regional Investment Opportunity
8.2.2 Industry Investment Opportunity
8.3 Investment Calculation
8.3.1 Cost Calculation
8.3.2 Revenue Calculation
8.3.3 Economic Performance Evaluation
PART 9 CONCLUSION
1.1 Insulin Industry
1.1.1 Definition
1.1.2 Industry Trend
1.2 Industry Chain
1.2.1 Upstream
1.2.2 Technology
1.2.3 Cost Structure
1.2.4 Consumer Preference
1.2.2 Downstream
PART 2 INDUSTRY OVERALL
2.1 Industry History
2.2 Development Prospect
2.3 Competition Structure
2.4 Relevant Policy
2.5 Trade Overview
PART 3 INSULIN MARKET BY PRODUCT
3.1 Products List of Major Companies
3.2 Market Size
3.3 Market Forecast
4 KEY COMPANIES LIST
4.1 Novartis (Company Overview, Sales Data etc.)
4.1.1 Company Overview
4.1.2 Products and Services
4.1.3 Business Analysis
4.2 Novo Nordisk (Company Overview, Sales Data etc.)
4.2.1 Company Overview
4.2.2 Products and Services
4.2.3 Business Analysis
4.3 Boehringer Ingelheim (Company Overview, Sales Data etc.)
4.3.1 Company Overview
4.3.2 Products and Services
4.3.3 Business Analysis
4.4 Bristol-Myers Squibb (Company Overview, Sales Data etc.)
4.4.1 Company Overview
4.4.2 Products and Services
4.4.3 Business Analysis
4.5 MannKind (Company Overview, Sales Data etc.)
4.5.1 Company Overview
4.5.2 Products and Services
4.5.3 Business Analysis
4.6 MannKind (Company Overview, Sales Data etc.)
4.6.1 Company Overview
4.6.2 Products and Services
4.6.3 Business Analysis
4.7 Sanofi (Company Overview, Sales Data etc.)
4.7.1 Company Overview
4.7.2 Products and Services
4.7.3 Business Analysis
4.8 Merck (Company Overview, Sales Data etc.)
4.8.1 Company Overview
4.8.2 Products and Services
4.8.3 Business Analysis
4.9 Bioton (Company Overview, Sales Data etc.)
4.9.1 Company Overview
4.9.2 Products and Services
4.9.3 Business Analysis
4.10 GEA (Company Overview, Sales Data etc.)
4.10.1 Company Overview
4.10.2 Products and Services
4.10.3 Business Analysis
4.11 Emisphere (Company Overview, Sales Data etc.)
4.12 Salix Pharmaceuticals (Company Overview, Sales Data etc.)
4.13 Gan & Lee (Company Overview, Sales Data etc.)
4.14 Dongbao (Company Overview, Sales Data etc.)
4.15 United Laboratories (TUL) (Company Overview, Sales Data etc.)
4.16 Takeda Pharmaceutical Company (Company Overview, Sales Data etc.)
4.17 Shihuida PHARMA Group (Company Overview, Sales Data etc.)
4.18 Henan Tian Fang Pharmaceutical (Company Overview, Sales Data etc.)
4.19 Disha Pharmaceutical Group (Company Overview, Sales Data etc.)
PART 5 MARKET COMPETITION
5.1 Companies Competition
5.2 Industry Competition Structure Analysis
5.2.1 Rivalry
5.2.2 Threat of New Entrants
5.2.3 Substitutes
5.2.4 Bargaining Power of Suppliers
5.2.5 Bargaining Power of Buyers
PART 6 MARKET DEMAND BY SEGMENT
6.1 Demand Situation
6.1.1 Industry Application Status
6.1.2 Industry SWOT Analysis
6.1.2.1 Strengths
6.1.2.2 Weaknesses
6.1.2.3 Opportunities
6.1.2.4 Threats
6.2 Major Customer Survey
6.3 Demand Forecast
PART 7 REGION OPERATION
7.1 Regional Market
7.2 Production and Sales by Region
7.2.1 Production
7.2.2 Sales
7.2.3 Trade
7.3 Regional Forecast
PART 8 MARKET INVESTMENT
8.1 Market Features
8.1.1 Product Features
8.1.2 Price Features
8.1.3 Channel Features
8.1.4 Purchasing Features
8.2 Investment Opportunity
8.2.1 Regional Investment Opportunity
8.2.2 Industry Investment Opportunity
8.3 Investment Calculation
8.3.1 Cost Calculation
8.3.2 Revenue Calculation
8.3.3 Economic Performance Evaluation
PART 9 CONCLUSION
LIST OF TABLES
Table GLOBAL INSULIN MARKET 2012-2017, BY TYPE, IN USD MILLION
Table Global Insulin Market 2012-2017, by Type, in Volume
Table Global Insulin Market Forecast 2018-2023, by Type, in USD Million
Table Global Insulin Market Forecast 2018-2023, by Type, in Volume
Table Novartis Overview List
Table Insulin Business Operation of Novartis (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Novo Nordisk Overview List
Table Insulin Business Operation of Novo Nordisk (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Boehringer Ingelheim Overview List
Table Insulin Business Operation of Boehringer Ingelheim (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Bristol-Myers Squibb Overview List
Table Insulin Business Operation of Bristol-Myers Squibb (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table MannKind Overview List
Table Insulin Business Operation of MannKind (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table MannKind Overview List
Table Insulin Business Operation of MannKind (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Sanofi Overview List
Table Insulin Business Operation of Sanofi (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Merck Overview List
Table Insulin Business Operation of Merck (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Bioton Overview List
Table Insulin Business Operation of Bioton (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table GEA Overview List
Table Insulin Business Operation of GEA (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Emisphere Overview List
Table Insulin Business Operation of Emisphere (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Salix Pharmaceuticals Overview List
Table Insulin Business Operation of Salix Pharmaceuticals (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Gan & Lee Overview List
Table Insulin Business Operation of Gan & Lee (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Dongbao Overview List
Table Insulin Business Operation of Dongbao (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table United Laboratories (TUL) Overview List
Table Insulin Business Operation of United Laboratories (TUL) (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Takeda Pharmaceutical Company Overview List
Table Insulin Business Operation of Takeda Pharmaceutical Company (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Shihuida PHARMA Group Overview List
Table Insulin Business Operation of Shihuida PHARMA Group (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Henan Tian Fang Pharmaceutical Overview List
Table Insulin Business Operation of Henan Tian Fang Pharmaceutical (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Disha Pharmaceutical Group Overview List
Table Insulin Business Operation of Disha Pharmaceutical Group (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Global Insulin Sales Revenue 2012-2017, by Companies, in USD Million
Table Global Insulin Sales Revenue Share, by Companies, in USD Million
Table Global Insulin Sales Volume 2012-2017, by Companies, in Volume
Table Global Insulin Sales Revenue Share, by Companies in 2017, in Volume
Table Insulin Demand 2012-2017, by Application, in USD Million
Table Insulin Demand 2012-2017, by Application, in Volume
Table Insulin Demand Forecast 2018-2023, by Application, in USD Million
Table Insulin Demand Forecast 2018-2023, by Application, in Volume
Table Global Insulin Market 2012-2017, by Region, in USD Million
Table Global Insulin Market 2012-2017, by Region, in Volume
Table Insulin Market Forecast 2018-2023, by Region, in USD Million
Table Insulin Market Forecast 2018-2023, by Region, in Volume
Table GLOBAL INSULIN MARKET 2012-2017, BY TYPE, IN USD MILLION
Table Global Insulin Market 2012-2017, by Type, in Volume
Table Global Insulin Market Forecast 2018-2023, by Type, in USD Million
Table Global Insulin Market Forecast 2018-2023, by Type, in Volume
Table Novartis Overview List
Table Insulin Business Operation of Novartis (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Novo Nordisk Overview List
Table Insulin Business Operation of Novo Nordisk (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Boehringer Ingelheim Overview List
Table Insulin Business Operation of Boehringer Ingelheim (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Bristol-Myers Squibb Overview List
Table Insulin Business Operation of Bristol-Myers Squibb (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table MannKind Overview List
Table Insulin Business Operation of MannKind (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table MannKind Overview List
Table Insulin Business Operation of MannKind (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Sanofi Overview List
Table Insulin Business Operation of Sanofi (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Merck Overview List
Table Insulin Business Operation of Merck (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Bioton Overview List
Table Insulin Business Operation of Bioton (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table GEA Overview List
Table Insulin Business Operation of GEA (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Emisphere Overview List
Table Insulin Business Operation of Emisphere (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Salix Pharmaceuticals Overview List
Table Insulin Business Operation of Salix Pharmaceuticals (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Gan & Lee Overview List
Table Insulin Business Operation of Gan & Lee (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Dongbao Overview List
Table Insulin Business Operation of Dongbao (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table United Laboratories (TUL) Overview List
Table Insulin Business Operation of United Laboratories (TUL) (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Takeda Pharmaceutical Company Overview List
Table Insulin Business Operation of Takeda Pharmaceutical Company (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Shihuida PHARMA Group Overview List
Table Insulin Business Operation of Shihuida PHARMA Group (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Henan Tian Fang Pharmaceutical Overview List
Table Insulin Business Operation of Henan Tian Fang Pharmaceutical (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Disha Pharmaceutical Group Overview List
Table Insulin Business Operation of Disha Pharmaceutical Group (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Global Insulin Sales Revenue 2012-2017, by Companies, in USD Million
Table Global Insulin Sales Revenue Share, by Companies, in USD Million
Table Global Insulin Sales Volume 2012-2017, by Companies, in Volume
Table Global Insulin Sales Revenue Share, by Companies in 2017, in Volume
Table Insulin Demand 2012-2017, by Application, in USD Million
Table Insulin Demand 2012-2017, by Application, in Volume
Table Insulin Demand Forecast 2018-2023, by Application, in USD Million
Table Insulin Demand Forecast 2018-2023, by Application, in Volume
Table Global Insulin Market 2012-2017, by Region, in USD Million
Table Global Insulin Market 2012-2017, by Region, in Volume
Table Insulin Market Forecast 2018-2023, by Region, in USD Million
Table Insulin Market Forecast 2018-2023, by Region, in Volume
LIST OF FIGURES
Figure Insulin Industry Chain Structure
Figure Global Insulin Market Growth 2012-2017, by Type, in USD Million
Figure Global Insulin Market Growth 2012-2017, by Type, in Volume
Figure Global Insulin Sales Revenue Share, by Companies in 2017, in USD Million
Figure Global Insulin Sales Volume Share 2012-2017, by Companies, in Volume
Figure Production Development by Region
Figure Sales List by Region
Figure Insulin Industry Chain Structure
Figure Global Insulin Market Growth 2012-2017, by Type, in USD Million
Figure Global Insulin Market Growth 2012-2017, by Type, in Volume
Figure Global Insulin Sales Revenue Share, by Companies in 2017, in USD Million
Figure Global Insulin Sales Volume Share 2012-2017, by Companies, in Volume
Figure Production Development by Region
Figure Sales List by Region
